Author： Kleiman N.S.
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.20, Iss.1, 1999-01, pp. : 43-57
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A Risk-Benefit Assessment of Amifostine in Cytoprotection
By Mabro M.
Drug Safety, Vol. 21, Iss. 5, 1999-11 ,pp. :
Access to resources
Recommend
A Risk-Benefit Assessment of Antileukotrienes in Asthma
By Smith L.J.
Drug Safety, Vol. 19, Iss. 3, 1998-09 ,pp. :
A Risk-Benefit Assessment of Oxytocics in Obstetric Practice
Drug Safety, Vol. 20, Iss. 4, 1999-04 ,pp. :
A Risk-Benefit Assessment of Aprotinin in Cardiac Surgical Procedures
Drug Safety, Vol. 18, Iss. 1, 1998-01 ,pp. :
A Risk-Benefit Assessment of HIV Protease Inhibitors
Drug Safety, Vol. 20, Iss. 4, 1999-04 ,pp. :